Next, ALYREF was found to be upregulated in hepatocellular carcinoma and oral squamous cell carcinoma, and it may have an effect on tumorigenesis via cell cycle regulation and mitosis (Saito et al., 2013; He et al., 2020). The gene discussed is ALYREF; the disease is hepatocellular carcinoma.